spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  ZEAL 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 3 Jun 2026
Medtronic Announces Strategic Investments to Support Future Expansion of Cardiac Ablation Portfolio as Physician Demand for Affera(TM) Technologies Broadens
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2026
AbbVie Announces Positive CHMP Opinion for MAVIRET(R) (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C Infection
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Feb 2026
Norgine Welcomes Positive CHMP Opinion Recommending Approval of Mavorixafor in the European Union for WHIM Syndrome
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Jan 2026
Affera(TM) momentum continues as Medtronic announces CE Mark in Europe and U.S. IDE First Cases for Sphere-360™ PFA Catheter to Treat Paroxysmal Atrial Fibrillation
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 29 Oct 2025
CustoMED Announces $6M Funding to Scale AI-Powered 3D Printed Solutions for Orthopedic Surgery
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 22 Oct 2025
Oticon Introduces the World's Smallest Powerhouse: Oticon Intent(TM) miniBTE R with Two Fitting Levels
Devices Product Launch
 HSMN NewsFeed - 7 Oct 2025
Cardinal Health Launches a New All-In-One Solution for Deep Vein Thrombosis and Pulmonary Embolism Prevention
Devices Product Launch
 HSMN NewsFeed - 23 May 2025
England's NICE Recommends FILSPARI(R) (sparsentan) as a Treatment Option for IgA Nephropathy
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Mar 2025
Photocure Appoints Jane Healy as Vice President and General Manager EMEA
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Feb 2024
Efemoral Medical Granted Breakthrough Device Designation
Devices Interventional FDA
 HSMN NewsFeed - 14 Nov 2023
FDA Clears Sirius Pintuition(R) for Long-term and Soft Tissue Implantation
Devices Oncology Surgery FDA
 HSMN NewsFeed - 23 Oct 2023
Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest
Devices Cardiology FDA
 HSMN NewsFeed - 2 Aug 2023
Body Vision Medical Forges Exclusive Distribution Agreements to Extend Global Access to LungVision(TM) AI Imaging System
Devices Radiology Surgery Distribution
 HSMN NewsFeed - 10 Aug 2022
New Embolic Device Demonstrates Superior Vessel Filling in Tumor Models
Devices Interventional
 HSMN NewsFeed - 29 Mar 2022
Medline and Hologenix Partner on New Curad Performance Series Line Powered By Celliant
Devices Orthopaedic Distribution
 HSMN NewsFeed - 9 Mar 2022
Metastatic Tumor Treatment with Novel GPX Embolic Device
Devices Interventional Oncology
 HSMN NewsFeed - 18 Feb 2022
Azurity Pharmaceuticals Announces Richard Blackburn as New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2022
Fluidx Medical's Embolic Demonstrates Novel Visibility Advantage
Devices Interventional
 HSMN NewsFeed - 20 Jan 2022
GPX Embolic Device Success in Challenging Tumor Case
Devices Interventional
 HSMN NewsFeed - 1 Dec 2021
Fluidx Medical Technology Announces Series A Led by Multinational Strategic Investor
Devices Venture Capital
 HSMN NewsFeed - 24 Aug 2021
European Commission Approves RINVOQ(R) (upadacitinib) as First JAK Inhibitor in the European Union for the Treatment of Both Adults and Adolescents with Moderate to Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 18 Aug 2021
Zimmer Biomet Receives FDA Clearance for ROSA(R) Hip System for Robotically-Assisted Direct Anterior Total Hip Arthroplasty
Devices Orthopaedic FDA
 HSMN NewsFeed - 22 Jun 2021
MolecuLight Signs LMT Surgical as New Distributor for Australia and New Zealand
Devices Wound Care Distribution
 HSMN NewsFeed - 1 Jun 2021
100th Elekta Unity MR-Linac goes to St George's Hospital in New Zealand
Devices Oncology
 HSMN NewsFeed - 20 May 2021
TricValve(R) Transcatheter Bicaval Valves System Receives CE Mark
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 23 Apr 2021
GLOBAL Sarcoma Therapy Now Approved for Australian Patients
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 15 Apr 2021
Juniper Biologics Announces the Appointment of Raman Singh as Chief Executive
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2021
Novel Embolic Device Used for Arterial and Venous Tumor Treatments
Devices Interventional
 HSMN NewsFeed - 14 Dec 2020
Efemoral Medical Announces Successful First-In-Human Use of the Efemoral(TM) Vascular Scaffold System
Devices Interventional
 HSMN NewsFeed - 24 Nov 2020
New Embolic Device Used in Interventional Oncology for Highly Targeted Tumor Treatment
Devices Interventional Oncology
 HSMN NewsFeed - 24 Nov 2020
Signifier Medical Technologies appoints Alastair Maxwell as Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 19 Nov 2020
LimaCorporate Announces FDA Approval for an IDE Study on SMR Stemless Reverse Shoulder System
Devices Orthopaedic FDA
 HSMN NewsFeed - 9 Nov 2020
OrbusNeich(R) Medical and P+F Products & Features(R) announce new partnership
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 30 Oct 2020
PolyActiva appoints Tracy Valorie, ophthalmic industry expert and former Bausch & Lomb executive, to its Board of Directors
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 8 Oct 2020
Signifier Medical Technologies appoints Travis Nieman as Managing Director International
Devices Personnel
 HSMN NewsFeed - 28 Sep 2020
BioShin, Biohaven's Asia-Pacific Subsidiary, Raises $60M in Series A Funding to Advance Neuroscience Pipeline in Asia-Pacific Region
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 24 Sep 2020
Leap Therapeutics Announces FDA Fast Track Designation Granted to DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Sep 2020
New Treatment for Urethral Strictures, Optilume(R), Receives CE Approval
Devices Urology Regulatory
 HSMN NewsFeed - 16 Sep 2020
Medtronic TYRX(TM) Absorbable Antibacterial Envelope Is Cost Effective for Patients at Increased Risk of Infections
Devices Cardiology
 HSMN NewsFeed - 16 Sep 2020
Signifier Medical Technologies Closes $10M Series C Funding Round
Devices Venture Capital
 HSMN NewsFeed - 15 Sep 2020
Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Aug 2020
Mylan and Biocon Biologics Announce Launch of Semglee(TM) (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 24 Aug 2020
Leap Therapeutics Expands Leadership Team with Addition of Two Industry Veterans
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 May 2020
XTANDI(R) (enzalutamide) Approved by Japan MHLW for the Treatment of Prostate Cancer with Distant Metastasis
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Apr 2020
FoRx Therapeutics AG Raises EUR 10 Million Seed Round and Becomes First Company to Develop a Pipeline of Drugs Targeting DNA Replication Stress for Cancer
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 13 Apr 2020
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2020
FDA expedites approval of Cochlear's Remote Check solution for cochlear implants
Devices FDA Product Launch
 HSMN NewsFeed - 9 Mar 2020
U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Bevacizumab for Review
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Jan 2020
Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 19 Sep 2019
Vivex Biologics, Inc. Announces Peter Wehrly as the New CEO of the Company
Regenerative Medicine Personnel
 HSMN NewsFeed - 12 Sep 2019
REDUCE FMR Study Shows Cardiac Dimensions' Carillon(R) System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Sep 2019
DePuy Synthes Expands ATTUNE Knee Platform with Cementless Option
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 29 Aug 2019
Richard Creager Joins Ubiquitome Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 30 Jul 2019
Aridis Pharmaceuticals Enters Into Equity Purchase and Option Agreements with The Serum Institute of India, Ltd for Exclusive License to Products and MabIgX(R) Platform Technology
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Jun 2019
Thommen Medical USA Announces Leadership Changes To Drive New Market Position
Devices Dental Personnel
 HSMN NewsFeed - 14 May 2019
Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore
Devices Oncology
 HSMN NewsFeed - 25 Apr 2019
CSL Behring Delivers on its Continued Commitment to Alpha 1 Patients with FDA Approval of Convenient Single-Vial Dosing for ZEMAIRA(R) [Alpha1-Proteinase Inhibitor (Human)]
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 17 Apr 2019
ViewRay Partners with Largest Independent Distributor in Australia and New Zealand to Bring Benefits of MRI-Guided Radiation Therapy to the Region
Devices Oncology Distribution
 HSMN NewsFeed - 10 Apr 2019
Rapid Dose Therapeutics Appoints Chief Financial Officer and Provides Business Update
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 9 Apr 2019
FDA Clears VITROS(R) XT Chemistry Product Slides from Ortho Clinical Diagnostics
Diagnostics FDA
 HSMN NewsFeed - 13 Mar 2019
Alvotech Enrolls First Patient in Clinical Phase III Study Involving Biosimilar Version of HUMIRA(R)
Biopharmaceuticals Generics Dermatology
 HSMN NewsFeed - 4 Mar 2019
Important New Trial With Oral FERACCRU(R) Shows Comparable Efficacy to IV Iron (Ferric Carboxymaltose), Offering a Real Alternative to Hospital Administration for Many Patients[4]
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2018
Olympus Spiration(R) Valve System Is FDA Approved for the Endobronchial Treatment of Emphysema
Devices FDA
 HSMN NewsFeed - 23 Nov 2018
Precision Oncology Company Guardant Health AMEA announces launch of its Asia, Middle East and Africa regional headquarters in Singapore
Diagnostics Oncology
 HSMN NewsFeed - 19 Oct 2018
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri(R), Biosimilar Trastuzumab
Biopharmaceuticals Generics Oncology Regulatory
 HSMN NewsFeed - 2 Oct 2018
ViewRay Appoints Industry Veteran James Alecxih as Chief Commercial Officer
Devices Oncology Radiology Personnel
 HSMN NewsFeed - 10 Sep 2018
Medivir Appoints Dr. Linda Basse as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Aug 2018
New Analysis Identifies Patient Populations With Cancer-associated VTE Who Could Benefit From Treatment With Oral, Once-daily LIXIANA(R) (edoxaban)
Biopharmaceuticals
 HSMN NewsFeed - 9 Aug 2018
MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia
Devices Regenerative Medicine Regulatory
 HSMN NewsFeed - 28 Jun 2018
Lupin and Mylan Partner to Commercialize Enbrel(R) (Etanercept) Biosimilar
Biopharmaceuticals Generics
 HSMN NewsFeed - 7 Jun 2018
MiMedx Announces Executive to Lead its International Operations and Provides Update on Company's International Progress
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 5 Jun 2018
Volpara Solutions Launches Enhanced Volpara(R)Positioning(TM) Software Featuring New Approach to Standardizing Mammographic Image Evaluation
Devices Radiology Product Launch
 HSMN NewsFeed - 31 May 2018
TELA Bio(R) Announces Plans to Launch OviTex(R) Reinforced BioScaffolds in Europe
Devices Surgery Product Launch
 HSMN NewsFeed - 16 May 2018
TapImmune Creates Scientific Advisory Board to Support Clinical Development of Multi-Antigen Cell Therapy Platform
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 May 2018
Beckman Coulter Launches the DxH 900 Hematology Analyzer
Devices Diagnostics Product Launch
 HSMN NewsFeed - 13 Apr 2018
Ampio Updates Regulatory, Clinical and NYSE Activities
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Feb 2018
Photocure Announces U.S. FDA Approval of New Indication for Blue Light Cystoscopy with Cysview(R)
Devices Oncology FDA
 HSMN NewsFeed - 15 Feb 2018
Arterys Receives First FDA Clearance for Broad Oncology Imaging Suite with Deep Learning
Devices Radiology Oncology FDA
 HSMN NewsFeed - 15 Feb 2018
Edwards' Self-Expanding Transcatheter Heart Valve Receives CE Mark
Devices Cardiology Regulatory
 HSMN NewsFeed - 13 Feb 2018
SANUWAVE Announces Strategic Partnership With Premier Shockwave
Devices Wound Care
 HSMN NewsFeed - 24 Jan 2018
Achieve Announces Expansion of Partnership with the University of Bristol for Next Generation Cytisine-Based Therapies to Include Exclusive Rights for Cytisine Development Across Multiple Therapeutic Categories
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 Dec 2017
Millar, Inc. Announces the Sale of Life Sciences Telemetry Product Line to Kaha Sciences
Devices Monitoring Acquisitions
 HSMN NewsFeed - 5 Dec 2017
AccuTec Blades(R) Announces Exclusive Australia-New Zealand DermaBlade(R) Agreement
Devices Dermatology Oncology Distribution
 HSMN NewsFeed - 20 Nov 2017
Volpara Receives Regulatory Clearances in Japan and Taiwan
Devices Radiology Oncology Regulatory
 HSMN NewsFeed - 25 Oct 2017
Sobi: Alprolix(R) Approved in the Kingdom of Saudi Arabia for the Treatment of Haemophilia B
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Sep 2017
Mark Fladrich Takes Office as the New CCO of the Grünenthal Group
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 May 2017
Saluda Medical Secures AU$53 Million in Series D Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 18 May 2017
Swedish Orphan Biovitrum AB - Elocta(R) Approved in the Kingdom of Saudi Arabia for the Treatment of Haemophilia A
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 May 2017
Edwards' Novel Self-Expanding Transcatheter Heart Valve Demonstrates Excellent Early Patient Outcomes
Devices Interventional Cardiology
 HSMN NewsFeed - 2 May 2017
Medeon Biodesign Announces Approval to Begin CE Clinical Study for the XPro(TM) Large Bore Vascular Closure System
Devices Interventional Regulatory
 HSMN NewsFeed - 1 May 2017
Ampio Initiates Pivotal Trial of Ampion(TM)
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 27 Apr 2017
SANUWAVE Announces Cooperation With Ortho-Medico in Europe and Exhibition at EWMA -- Visit Us at Booth Number 3 E14
Devices Wound Care Distribution
 HSMN NewsFeed - 25 Apr 2017
ResMed Unveils AirMini – the World’s Smallest CPAP
Devices Product Launch
 HSMN NewsFeed - 21 Apr 2017
Eight Weeks of Treatment with AbbVie's Investigational, Pan-Genotypic Regimen of Glecaprevir/Pibrentasvir (G/P) Achieved High SVR(12) Rates in Challenging to Treat Genotype 3 Chronic Hepatitis C
Biopharmaceuticals
 HSMN NewsFeed - 19 Apr 2017
Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 18 Apr 2017
FDA Releases gammaCore(R), the First Non-Invasive Vagus Nerve Stimulation Therapy Applied at the Neck for Acute Treatment of Pain Associated with Episodic Cluster Headache in Adult Patients
Devices FDA
 HSMN NewsFeed - 12 Apr 2017
Cxbladder Monitor Significantly Outperforms All Compared FDA Approved Urine Tests For Bladder Cancer; Enhancing The Standard Of Care For Bladder Cancer Patients
Diagnostics Urology Oncology
 HSMN NewsFeed - 7 Apr 2017
K2M Group Holdings, Inc. & LifeHealthcare Group Limited Announce New Distribution Agreement for Australia & New Zealand
Devices Orthopaedic Neurosurgery Distribution
 HSMN NewsFeed - 13 Mar 2017
Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin(R)
Biopharmaceuticals Oncology Generics Licensing
 HSMN NewsFeed - 2 Mar 2017
ALK Announces FDA Approval for its House Dust Mite Sublingual Allergy Immunotherapy Tablet (ACARIZAX(R) in Europe)
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Jan 2017
Microbix Appoints Meridian Life Science as Distributor in Asia Pacific
Diagnostics Distribution
 HSMN NewsFeed - 12 Jan 2017
Derma Sciences Buys MEDIHONEY(R) Brand From Long-Term Partner
Regenerative Medicine Wound Care Acquisitions
 HSMN NewsFeed - 11 Jan 2017
Study Results Published in the Journal of the American Medical Association Show Amgen's Parsabiv(TM) (Etelcalcetide) Significantly Reduced Serum Parathyroid Hormone in Adults With Secondary Hyperparathyroidism on Hemodialysis
Biopharmaceuticals
 HSMN NewsFeed - 6 Jan 2017
OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. Announce Definitive Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Nov 2016
ReVision Optics Raises $32 Million to Fund Expansion of U.S. Commercialization of Raindrop(R) Near Vision Inlay
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 8 Nov 2016
Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant for Contrave(R) (naltrexone HCl / bupropion HCl extended release) in Australia and New Zealand
Biopharmaceuticals Distribution
 HSMN NewsFeed - 2 Nov 2016
Cardinal Health Announces New Strategic Distribution Agreements to Expand Cordis' Cardiovascular Product Offerings in Asia Pacific
Devices Cardiology Distribution
 HSMN NewsFeed - 28 Oct 2016
The Successful Worldwide First in Human Implantation of an Innovative Aortic Valve from Colibri Heart Valve and Venus Medtech with Disruptive "Dry Tissue" Technology Conducted
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Oct 2016
Valencia Technologies' eCoin to be Showcased at TCT 2016 Both for its Premiere Presentation of First-in-Human Clinical Trial Results and as a Novel Hypertension Therapy
Devices Cardiology Neurology
 HSMN NewsFeed - 24 Oct 2016
Baxter Launches HDx Therapy Enabled by THERANOVA to Provide High Performance Hemodialysis Treatments
Devices Product Launch
 HSMN NewsFeed - 20 Oct 2016
Akesys Medical and Elixir Medical Announce First Human Implant of the PRAVA(TM) Bioresorbable Scaffold for Peripheral Vascular Disease
Devices Interventional
 HSMN NewsFeed - 6 Oct 2016
Kamada Announces Extension of GLASSIA(R) Supply and Distribution Agreement with Shire with Minimum $237 Million of Revenue for the Years 2017 to 2020
Biopharmaceuticals Distribution Licensing
 HSMN NewsFeed - 30 Sep 2016
Threshold Pharmaceuticals Announces Interim Results from Tarloxotinib Program and its Plans to Focus on Evofosfamide and Earlier-Stage Opportunities
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Sep 2016
WOUNDCHEK(TM) Protease Status receives market clearance in Australia
Diagnostics Wound Care Regulatory
 HSMN NewsFeed - 2 Aug 2016
Meda Shareholders Representing Approximately 94% of Meda Shares Accept Mylan Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Jul 2016
LabStyle Innovations Corp. Executes Distribution Partnership with GEMCO Medical
Devices Monitoring Distribution
 HSMN NewsFeed - 1 Jul 2016
Patients with Colorectal Cancer Liver Metastases Had Significantly Greater Depth of Tumour Response to SIR-Spheres(R) Y-90 resin microspheres, New SIRFLOX Analysis Shows
Devices Oncology
 HSMN NewsFeed - 21 Jun 2016
Perrigo Announces FDA Clearance And Launch Of Non-GMO* Infant Formulas For The U.S. Store Brand Market
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 13 May 2016
Alprolix(R) (rFIXFc) approved in the EU for the treatment of haemophilia B
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 May 2016
SI-BONE, Inc. Surpasses 20,000 Surgeries With Triangular iFuse Implant System - Expands International Presence to 25 Countries
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 27 Apr 2016
MedDay Appoints Catherine Moukheibir as Chairman of its Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 7 Apr 2016
Cipher Pharmaceuticals Proposes Adding Rosemary A. Crane and Dr. Renee P. Tannenbaum To Board of Directors
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 31 Mar 2016
SIR-Spheres(R) Y-90 Resin Microspheres Are a Well-Tolerated Alternative to Standard Therapies for Inoperable Primary Liver Cancer, New UK NICE Medtech Innovation Briefing Says
Devices Oncology
 HSMN NewsFeed - 23 Feb 2016
SIRFLOX Study Published in Journal of Clinical Oncology
Devices Interventional Radiology Oncology
 HSMN NewsFeed - 5 Feb 2016
Novogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Feb 2016
PharmaMar and Specialised Therapeutics Asia Sign Licensing and Marketing Agreement for APLIDIN(R) (plitidepsin) Covering Several Asian Countries
Biopharmaceuticals Oncology Licensing Distribution
 HSMN NewsFeed - 25 Jan 2016
Athenex Announces US FDA Allowance of the Investigation New Drug Application of Oradoxel, the Proprietary Oral Form of Docetaxel
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Jan 2016
BONESUPPORT(TM) Announces Appointment Of Life Sciences Industry Veteran, Richard Davies, As New Chief Executive Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 12 Jan 2016
Boston Scientific Launches the LithoVue(TM) Single-Use Digital Flexible Ureteroscope in U.S. and Europe
Devices Urology Product Launch
 HSMN NewsFeed - 11 Jan 2016
FDA Approves Animas(R) Vibe(R) Insulin Pump and Continuous Glucose Monitoring System For Use in Children
Devices Endocrinology Monitoring FDA
 HSMN NewsFeed - 21 Dec 2015
Oral REVLIMID(R) Plus Dexamethasone Granted Approval for Treatment of Patients with Newly Diagnosed Multiple Myeloma in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 3 Dec 2015
Mundipharma Establishes an Ophthalmology Business by Acquiring MSD's Portfolio of Glaucoma Products
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 2 Dec 2015
Surefire Medical Closes $15M Series C Financing Led by Tullis Health Investors
Devices Interventional Radiology Oncology Venture Capital
 HSMN NewsFeed - 30 Nov 2015
Three-Year Follow-Up Data From Lombard Medical Aorfix(TM) PYTHAGORAS Pivotal Trial Presented at 42nd Annual VEITHsymposium(TM)
Devices Interventional
 HSMN NewsFeed - 24 Nov 2015
Sobi and Biogen’s ELOCTA(R) (rFVIIIFc) Approved in Europe for the Treatment of Haemophilia A
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Oct 2015
CareFusion Signs Exclusive Distribution Agreement With AAM Healthcare For Video Laryngoscope
Devices Distribution
 HSMN NewsFeed - 1 Sep 2015
Surefire Medical Receives FDA Clearance for Precision Direct-to-Tumor Embolization Device
Devices Drug Delivery Interventional Oncology FDA
 HSMN NewsFeed - 30 Jun 2015
First Clinical Cases Performed Using Lombard Medical's Aorfix(TM) Plus Endovascular Stent Graft
Devices Interventional
 HSMN NewsFeed - 11 May 2015
PaxVax Appoints Nima Farzan Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2015
Clear Guide Medical Receives CE Mark on the Clear Guide ONE
Devices Interventional Regulatory
 HSMN NewsFeed - 23 Mar 2015
EUSA Pharma Successfully Launches as an Independent Profitable Pharmaceutical Business with Global Reach and a Portfolio of Specialty Products Acquired from Jazz Pharmaceuticals
Biopharmaceuticals Acquisitions Product Launch
 HSMN NewsFeed - 18 Mar 2015
Hong Kong Authority Approves Abraxane(R) as First-Line Treatment For Late-Stage Pancreatic Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Mar 2015
Sirtex Reports Preliminary SIRFLOX Study Results
Devices Drug Delivery Oncology
 HSMN NewsFeed - 20 Feb 2015
REVLIMID(R) (Lenalidomide) Approved by the European Commission for the Treatment of Adult Patients with Previously Untreated Multiple Myeloma who are Not Eligible for Transplant
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 12 Nov 2014
Beverly Huss Joins Surefire Medical Board of Directors
Devices Interventional Oncology Drug Delivery Personnel
 HSMN NewsFeed - 30 Oct 2014
Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing
Devices Orthopaedic Personnel Mergers & Acquisitions
 HSMN NewsFeed - 16 Oct 2014
Lombard Medical Announces First Aorfix(TM) Cases in New Zealand Following Expansion in Asia-Pacific Region
Devices Interventional
 HSMN NewsFeed - 8 Sep 2014
Titan Spine Announces Guarantee for Its Spinal Interbody Fusion Devices
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 8 Sep 2014
Prospective Clinical Data On Web Aneurysm Embolization System Demonstrate Excellent Safety And High Rate Of Stable Occlusion In Difficult To Treat Aneurysms
Devices Interventional Neurology
 HSMN NewsFeed - 26 Aug 2014
Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jul 2014
Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 14 Jul 2014
Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 1 Jul 2014
Alere Announces Management Transition
Devices Monitoring Personnel
 HSMN NewsFeed - 27 Jun 2014
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor) in Eight Non-G551D Gating Mutations
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Jun 2014
Titan Spine Receives Market Registration Approval in Australia and New Zealand for its Endoskeleton(R) Interbody Fusion Devices
Devices Orthopaedic Neurosurgery Regulatory
 HSMN NewsFeed - 21 May 2014
Boston Scientific Reports Strong Performance Data For SYNERGY(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2014
Genkyotex Announces New Senior Management and Board Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 May 2014
Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve(R) 100 Novolimus Eluting Coronary Scaffold System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 1 May 2014
Dr. Edward Rudnic Appointed CEO of QRxPharma
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Apr 2014
SI-BONE, Inc. Closes $33 Million Growth Capital Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 23 Apr 2014
Surefire Medical's Groundbreaking COSY Clinical Trial Results Presented at ECIO: Is Coiling Prior to Radioembolization Still Necessary in Minimally Invasive Treatment of Liver Cancer?
Devices Interventional Oncology
 HSMN NewsFeed - 20 Mar 2014
St. Jude Medical Announces European Launch of Prodigy Spinal Cord Stimulation System with Burst Technology
Devices Neurology Product Launch
 HSMN NewsFeed - 19 Mar 2014
RaySearch Secures Distribution of Raystation(R) in Australia and New Zealand
Devices Oncology Distribution
 HSMN NewsFeed - 13 Mar 2014
Surefire Medical Receives FDA Clearance, CE Mark For New Line Of Guiding Catheters
Devices Interventional FDA
 HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 10 Feb 2014
Sunesis Appoints Joseph I. DePinto as Chief Commercial Officer, Updates VALOR Timeline to Unblinding of Data
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Feb 2014
LabStyle Innovation Signs Agreement with uHealth to Exclusively Distribute the Dario(TM) Blood Glucose Monitoring Device in Australia
Devices Monitoring Endocrinology Distribution
 HSMN NewsFeed - 3 Feb 2014
Mylan Launches First Trastuzumab Biosimilar, Hertraz(TM), in India
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 29 Jan 2014
Pacific Edge's Cxbladder(TM) Boosting Confidence in Bladder Cancer Detection
Diagnostics Oncology
 HSMN NewsFeed - 27 Jan 2014
Purdue Pharma L.P. Names Mark Timney President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jan 2014
VENITI, Inc. Announces First Uses of Veniti Vici Venous Stent System
Devices Interventional
 HSMN NewsFeed - 22 Jan 2014
Bioject's Distributor Meditrend International Receives Australian Device Registration
Devices Drug Delivery Distribution Regulatory
 HSMN NewsFeed - 17 Jan 2014
European Commission Grants Marketing Authorization for Gilead’s Sovaldi(R) (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Jan 2014
Integrity Applications Signs Distribution Agreement for GlucoTrack(R) Model DF-F Glucose Monitoring Device
Devices Monitoring Endocrinology Distribution
 HSMN NewsFeed - 18 Dec 2013
Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Dec 2013
QRxPharma Completes A$11.6 Million Capital Raising
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Dec 2013
VIVUS Announces License and Commercialization Agreement With Sanofi for Avanafil in Africa, Middle East, Turkey and CIS/Russia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Dec 2013
U.S. Food and Drug Administration Approves Gilead’s Sovaldi(TM) (Sofosbuvir) for the Treatment of Chronic Hepatitis C
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Dec 2013
Medtronic Announces CE Mark and TGA Listing for the Symplicity Spyral(TM) Multi-Electrode Catheter and Symplicity G3(TM) Generator
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 Nov 2013
GW Pharmaceuticals plc Announces Sativex(R) Regulatory Approval in Switzerland
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 14 Nov 2013
Long Term Follow Up Data On WEB Aneurysm Embolization System Demonstrate High Rate Of Stable Occlusion In Difficult To Treat Aneurysms
Devices Interventional
 HSMN NewsFeed - 14 Nov 2013
Svelte Medical Systems Announces Enrollment Complete in the DIRECT II Drug-Eluting Stent Study
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Nov 2013
Defibrotide Granted Orphan Drug Status in Australia
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Nov 2013
Surefire Medical Closes Series B Funding at $18.2 Million
Devices Oncology Venture Capital
 HSMN NewsFeed - 1 Nov 2013
Ferring Pharmaceuticals Appoints Alex Chang Senior Vice President, Asia Pacific
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Oct 2013
Elixir Medical Announces Excellent 1-Year Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve(R) Novolimus Eluting Coronary Scaffold System
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Oct 2013
Surefire Medical Launches mT Infusion System For Small Vessel Interventional Procedures
Devices Interventional Product Launch
 HSMN NewsFeed - 17 Oct 2013
Nuron Biotech Announces Appointment of New Management Team Members and Provides an Update on Commercial Vaccine Meningitec(TM)
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 11 Oct 2013
Auxilium Pharmaceuticals, Inc. Announces License Agreement For The Marketing Rights To STENDRA(TM) In The United States And Canada
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 Sep 2013
Surefire Medical's Anti-Reflux Infusion System May Eliminate Coiling, Lower Cost Of Embolization Procedures
Devices Drug Delivery Oncology
 HSMN NewsFeed - 6 Sep 2013
U.S. Food and Drug Administration Approves ABRAXANE(R) in Combination with Gemcitabine as First-Line Treatment of Patients with Metastatic Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Sep 2013
ULURU Inc. Extends The International Altrazeal(R) License To Include Additional Territories
Devices Wound Care Licensing
 HSMN NewsFeed - 4 Sep 2013
SANUWAVE Appoints Life Sciences Industry Executive, Alan L. Rubino To Its Board
Devices Wound Care Personnel
 HSMN NewsFeed - 4 Sep 2013
New Data Suggests Abbott's High Sensitive Troponin Test May Help Doctors More Accurately Diagnose Heart Attacks in Women
Diagnostics Cardiology
 HSMN NewsFeed - 29 Aug 2013
St. Jude Medical Receives European Approval for New Renal Denervation System That Reduces Total Ablation Time by More Than 80 Percent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 26 Aug 2013
ULURU Inc. Announces A Publication In The International Wound Journal On A Clinical Study Using Altrazeal(R)
Devices Wound Care
 HSMN NewsFeed - 23 Jul 2013
RaySearch Laboratories: RayStation(R) 4.0 Released
Devices Oncology Product Launch
 HSMN NewsFeed - 22 Jul 2013
GW Pharmaceuticals Files New Regulatory Application to Expand Sativex(R) Approval to France
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Jul 2013
Celgene Will Discontinue Phase III ORIGIN(R) Trial in Previously Untreated Elderly Patients with B-Cell Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Jul 2013
Zimmer Announces Distribution Of APEX Spine System
Devices Orthopaedic Neurosurgery Distribution
 HSMN NewsFeed - 9 Jul 2013
VIVUS Announces Avanafil Partnership With Menarini
Biopharmaceuticals Licensing
 HSMN NewsFeed - 25 Jun 2013
IsoRay Announces a New International Distributor in Australia and New Zealand
Devices Oncology Distribution
 HSMN NewsFeed - 4 Jun 2013
St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure
Devices Cardiology Interventional
 HSMN NewsFeed - 29 May 2013
K2M Introduces New Technology for Small Stature Patients in Australia, New Zealand, and European Spine Markets
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 28 May 2013
ULURU Inc. Announces Publication On Altrazeal(R) In The International Journal Of Molecular Sciences
Devices Wound Care
 HSMN NewsFeed - 24 May 2013
PBAC Approves XIFAXAN(R) (Rifaxamin α) 550 mg Cost Effectiveness in Australia
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 May 2013
Svelte Drug-Eluting Stent Utilizing New Class of Bioabsorbable Drug Coating Attains 0% Clinically-Driven Events Through 12-Months in First-In-Man Study
Devices Interventional Cardiology
 HSMN NewsFeed - 23 May 2013
One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology
Devices Cardiology
 HSMN NewsFeed - 22 May 2013
Boston Scientific Promus PREMIER(TM) and SYNERGY(TM) Drug-Eluting Stent Systems Provide Exceptional Safety and Efficacy Data
Devices Interventional Cardiology
 HSMN NewsFeed - 14 May 2013
St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN System
Devices Interventional Cardiology
 HSMN NewsFeed - 8 May 2013
Elixir Medical Announces FDA Approval to Commence EXCELLA III Clinical Trial with DESyne(R) Nx Novolimus Eluting Coronary Stent System in the United States
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 15 Mar 2013
RaySearch Laboratories: RayStation(R) 3.5 Released
Devices Oncology Product Launch
 HSMN NewsFeed - 1 Mar 2013
Studies Published in Pain Medicine Demonstrate Effectiveness of Minimally-Invasive Cooled Radiofrequency Treatment for Low Back Pain
Devices Orthopaedic
 HSMN NewsFeed - 1 Mar 2013
Wright Medical Group, Inc. Completes Acquisition of BioMimetic Therapeutics, Inc.
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 26 Feb 2013
Surefire Medical Receives CE Mark Approval for Next Generation Infusion System and Specialty Catheters
Devices Interventional Regulatory
 HSMN NewsFeed - 22 Feb 2013
EDAP's Ablatherm-HIFU Offers Reliable Therapy for Localized Prostate Cancer
Devices Urology Oncology
 HSMN NewsFeed - 8 Feb 2013
EDAP's Ablatherm-HIFU Demonstrates Long-Term Efficacy and Safety Over Fourteen-Year Period
Devices Oncology
 HSMN NewsFeed - 1 Feb 2013
EDAP Submits U.S. FDA Pre-Market Approval Application for Ablatherm(R)-HIFU for Treatment of Low Risk, Localized Prostate Cancer
Devices Oncology FDA
 HSMN NewsFeed - 30 Jan 2013
Svelte Medical Systems Announces Treatment of First Patient in the DIRECT II Drug-Eluting Stent Study
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Jan 2013
Abbott Initiates Clinical Trial of Absorb(TM) in the United States
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Dec 2012
U.S. Food and Drug Administration Accepts XIAFLEX(R) Supplemental Biologics License Application Filing for the Treatment of Peyronie's Disease
Biopharmaceuticals Urology
 HSMN NewsFeed - 11 Dec 2012
Sirtex Medical Limited Launches New Global Website for SIR-Spheres(R) Microspheres - A Form of Selective Internal Radiation Therapy (SIRT) for Liver Tumours
Devices Oncology
 HSMN NewsFeed - 7 Dec 2012
Dr. Reddy's Launches Debiopharm's Pamorelin(R) LA in India for the Treatment of Locally Advanced or Metastatic, Hormone-Dependent Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Dec 2012
Medical Device Veteran Peter Wehrly Joins NLT SPINE’s Board of Directors
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 30 Nov 2012
First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY(TM) Coronary Stent System Featuring a Bioabsorbable Polymer Coating
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Nov 2012
Dr. Reddy’s Announces the Appointment of New Chief Financial Officer (CFO) and Head for North America Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Nov 2012
Wright Medical Group, Inc. and BioMimetic Therapeutics, Inc. Enter into Agreement to Combine Businesses
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 24 Oct 2012
Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne(R) System
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Oct 2012
FDA Approves ABRAXANE(R) for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Oct 2012
LoneStar Heart Announces $20 Million Milestone Financing for Lead Product to Treat Heart Failure
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 2 Oct 2012
Sunesis Pharmaceuticals Announces Management Promotions
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Sep 2012
Osiris Therapeutics Regains Worldwide Rights to Prochymal and Chondrogen
Regenerative Medicine
 HSMN NewsFeed - 25 Sep 2012
Abbott Announces International Launch of the Absorb(TM) Bioresorbable Vascular Scaffold
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Aug 2012
Lilly Announces Retirement of Robert Armitage, Names Michael Harrington Senior Vice President and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Aug 2012
Dyax Corp. Creates COO Position and Expands Executive Roles
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jul 2012
FDA Clears First Ever Bi-directionally Retrievable Vena Cava Filter from Crux Biomedical
Devices Interventional FDA
 HSMN NewsFeed - 10 Jul 2012
Derma Sciences Receives CE Mark for MEDIHONEY(R) HCS
Devices Wound Care Regulatory
 HSMN NewsFeed - 15 Jun 2012
Biomet Announces Initial Closing of DePuy Trauma Acquisition
Devices Mergers & Acquisitions
 HSMN NewsFeed - 23 May 2012
Pfizer Names Olivier Brandicourt as President and General Manager, Emerging Markets and Established Products Business Units
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 May 2012
Elixir Medical Announces Excellent Results from DESolve I First-In-Man Study for the Fully Bioresorbable Drug Eluting Coronary Scaffold System
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2012
Elixir Medical Announces Continued Excellent One Year Safety and Efficacy Data from the EXCELLA BD Randomized Clinical Trial for DESyne BD(TM) Novolimus Eluting Coronary Stent with Biodegradable Polymer
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2012
Svelte Medical Systems Announces Final Patient Treated in the DIRECT Drug-Eluting Stent Study
Devices Interventional Cardiology
 HSMN NewsFeed - 8 May 2012
Covidien Introduces New Treatment for Drug-Resistant Hypertension
Devices Cardiology
 HSMN NewsFeed - 3 May 2012
ULURU Inc. Provides Update of Clinical Activities for Altrazeal
Devices Wound Care
 HSMN NewsFeed - 30 Apr 2012
Conceptus(R) Announces Settlement of Patent Infringement Lawsuit With Hologic
Devices Litigation
 HSMN NewsFeed - 19 Mar 2012
ZELTIQ Aesthetics, Inc. Names Mike Genau President of Its North American Franchise
Devices Personnel
 HSMN NewsFeed - 29 Feb 2012
Conceptus(R) Receives FDA Approval for Compatible Use of Hologic's NovaSure(R) with Essure(R) Inserts in Place
Devices
 HSMN NewsFeed - 23 Feb 2012
ULURU Inc. Announces Approval to Market Altrazeal(R) in Australia
Biopharmaceuticals Wound Care Regulatory
 HSMN NewsFeed - 20 Feb 2012
Plexxikon Announces European Approval of Zelboraf(R) for the Treatment of Patients With BRAF Mutation-Positive Metastatic Melanoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Jan 2012
Cytomedix Appoints Cathryn Hope as Vice President of Marketing
Regenerative Medicine Personnel
 HSMN NewsFeed - 17 Jan 2012
ULURU Inc. Completes Altrazeal(R) License Agreement for Europe
Devices Wound Care Licensing
 HSMN NewsFeed - 8 Dec 2011
Abbott Initiates Clinical Trial to Evaluate the Absorb(TM) Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Nov 2011
Getinge finalizes the acquisition of Atrium Medical Inc. and changes the date of its AGM
Devices Mergers & Acquisitions
 HSMN NewsFeed - 4 Nov 2011
Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Nov 2011
Ventus Medical Appoints Two Senior Executives
Devices Personnel
 HSMN NewsFeed - 27 Oct 2011
ULURU Inc. Announces Additional Data Supporting Altrazeal(R) Use in Diabetic Foot Ulcers
Devices Wound Care
 HSMN NewsFeed - 12 Oct 2011
Aircraft Medical Signs Multinational Distribution Agreement with Covidien for McGRATH® MAC Video Laryngoscope
Devices Distribution
 HSMN NewsFeed - 11 Oct 2011
Lilly Announces Changes in Senior Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Oct 2011
Conceptus(R) Acquires All Distribution Rights Related to the Essure(R) Procedure in the Netherlands
Devices Distribution
 HSMN NewsFeed - 3 Oct 2011
Ventus Medical Launches Provent(R) Sleep Apnea Therapy in Australia and New Zealand
Devices
 HSMN NewsFeed - 8 Sep 2011
Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia
Devices
 HSMN NewsFeed - 6 Sep 2011
Savient Announces the Election of William F. Owen, Jr., M.D. and David Y. Norton to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Aug 2011
FDA Approves Zelboraf (Vemurafenib) and Companion Diagnostic for BRAF Mutation-Positive Metastatic Melanoma, a Deadly Form of Skin Cancer
Biopharmaceuticals Oncology Personalized Medicine FDA
 HSMN NewsFeed - 12 Aug 2011
Misonix Announces New Distribution Agreement for Australia and New Zealand
Devices Distribution
 HSMN NewsFeed - 8 Aug 2011
Derma Sciences Achieves Key MEDIHONEY(R) Sales Milestone
Devices Wound Care
 HSMN NewsFeed - 8 Jul 2011
Medtronic Issues Communication about the Potential for Reduced Battery Performance in a Small Percentage of SynchroMed(R) II Implantable Drug Infusion Pumps
Devices Drug Delivery
 HSMN NewsFeed - 3 Jun 2011
Fox Chase Cancer Center Study Evaluating the Safety of Concurrent Chemotherapy and Selective Internal Radiation Therapy using SIR-Spheres(R) Microspheres Released at 2011 American Society of Clinical Oncology Annual Meeting
Devices Oncology
 HSMN NewsFeed - 25 May 2011
Cancer Research UK Signs Deal With Centella Therapeutics, Inc. to Launch Clinical Development of Radiotherapy-Enhancing Drug
Devices Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 24 May 2011
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
Devices Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 20 May 2011
Positive Clinical Outcomes Reported with Medtronic CoreValve(R) System
Devices Interventional Cardiology
 HSMN NewsFeed - 4 May 2011
Sectra Receives FDA Clearance FOR MicroDose Mammography Modality
Devices Radiology Oncology FDA
 HSMN NewsFeed - 4 May 2011
NxStage(R) Advances Global Growth Strategy with System One Regulatory Approval and Distribution Agreement in Australia and New Zealand
Devices Distribution
 HSMN NewsFeed - 18 Apr 2011
CoDa Therapeutics Closes $19 Million Series B Financing Round
Biopharmaceuticals Wound Care Venture Capital
 HSMN NewsFeed - 4 Apr 2011
Cameron Health Appoints Ward Dykstra as Vice President of Global Marketing
Devices Cardiology Personnel
 HSMN NewsFeed - 31 Mar 2011
RXi Pharmaceuticals Aggressively Moves into Late-Stage Clinical Development with the Agreement to Acquire Apthera, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 17 Mar 2011
Advanced Cardiac Therapeutics Initiates First-In-Man CE Mark Clinical Trial to Study Innovative Catheter System for the Treatment of Atrial Arrhythmias
Devices Cardiology Regulatory
 HSMN NewsFeed - 9 Mar 2011
Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX(R) Phase III Double-Blind Studies for Peyronie's Disease
Biopharmaceuticals
 HSMN NewsFeed - 25 Feb 2011
Medtronic Announces Purchase of Innovative Gel Technology for Potential Use in Functional Endoscopic Sinus Surgery (FESS)
Devices Surgery Acquisitions
 HSMN NewsFeed - 23 Feb 2011
Sunesis Receives FDA Fast Track Designation for Vosaroxin in AML
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Feb 2011
Erica L. Mann, Former Pfizer Executive, Appointed New President of Bayer HealthCare's Global Consumer Care Division
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jan 2011
Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY Drug-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Jan 2011
Genentech Personalized Investigational Medicine Shows Survival Benefit in Advanced Skin Cancer
Biopharmaceuticals Diagnostics Personalized Medicine
 HSMN NewsFeed - 14 Jan 2011
Orexo and Invida Jointly Announce Agreement for Abstral(TM) in Asia Pacific
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 11 Jan 2011
Dyax and Sigma-Tau Group Expand Agreement to Commercialize KALBITOR(R) (ecallantide) for Hereditary Angioedema
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Jan 2011
Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 3 Jan 2011
Inspire Announces Results of Second Phase 3 Trial with Denufosol for Cystic Fibrosis
Biopharmaceuticals
 HSMN NewsFeed - 8 Dec 2010
Johnson & Johnson Launches Recommended Public Offer to Acquire Crucell
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Nov 2010
Endologix Announces First Clinical Implant of Ventana Stent Graft
Devices Interventional
 HSMN NewsFeed - 20 Oct 2010
PinPointe FootLaser Receives FDA Clearance for the Treatment of Nail Fungus (Onychomycosis)
Devices FDA
 HSMN NewsFeed - 22 Sep 2010
Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Long-Term Data Show Advantages for TAXUS(R) Liberte(R) Stent in Small Vessels and Long Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance in Second 'All Comers' Study
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Aug 2010
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA
Biopharmaceuticals Distribution
 HSMN NewsFeed - 20 Aug 2010
REVLIMID(R) Approved for Treatment of Deletion 5q Myelodysplastic Syndromes in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Aug 2010
Islanders and Tourists with Brain Cancer to Benefit from Hawaiian Center's Installment of Elekta's Leksell Gamma Knife Perfexion
Devices Oncology
 HSMN NewsFeed - 3 Aug 2010
Boston Scientific Begins Clinical Trial Enrollment for New Coronary Stent with Bioabsorbable Polymer and Everolimus Drug Coating
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Jul 2010
Devax Receives CE Mark for the AXXESS Drug Eluting Bifurcation Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 29 Jul 2010
Abraxis BioScience and Specialised Therapeutics Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 29 Jul 2010
CMP Therapeutics Appoints Dr Neill Moray Mackenzie as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jul 2010
Radient Pharmaceuticals Announces Exclusive Distribution Agreement With AMDL Australia Pty Ltd.
Biopharmaceuticals Diagnostics Distribution
 HSMN NewsFeed - 29 Jun 2010
King Pharmaceuticals Amends Strategic Alliance for REMOXY(R) in Europe
Biopharmaceuticals
 HSMN NewsFeed - 16 Jun 2010
Tranzyme Pharma and Norgine Sign License Agreement for Late-Stage Development Product, Ulimorelin (TZP-101), in Europe and Other Select Regions
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Jun 2010
ULURU Inc. Announces Senior Management Change
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 May 2010
Prolia(R) (Denosumab) Granted Marketing Authorization in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 May 2010
Volcano Introduces VIBE RX - the World's Only Vascular Imaging Balloon Catheter
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 25 May 2010
Abbott's Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
NEVO Sirolimus-eluting Coronary Stent Continues to Demonstrate Excellent Safety and Efficacy Outcomes in New Twelve-Month Data
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Apr 2010
ULURU Inc. Announces the Appointment of Dr. Jeffrey A. Stone to the Board of Directors
Biopharmaceuticals Drug Delivery Wound Care Personnel
 HSMN NewsFeed - 18 Mar 2010
Cameron Health Commences FDA-Approved IDE Clinical Trial of the Minimally Invasive Totally Subcutaneous Implantable Defibrillator for Treatment of Sudden Cardiac Arrest
Devices Cardiology
 HSMN NewsFeed - 3 Mar 2010
St. Jude Medical Announces Publication of Feasibility Results for Trial of Novel Heart Failure Management System
Devices Cardiology Monitoring
 HSMN NewsFeed - 25 Feb 2010
Derma Sciences Finalizes Licensing Agreement for Worldwide Rights to MEDIHONEY(R)
Devices Wound Care Licensing
 HSMN NewsFeed - 22 Feb 2010
Amedica(R) Signs Joint Venture Agreement With Orthopaedic Synergy(R)
Devices Orthopaedic
 HSMN NewsFeed - 18 Feb 2010
Derma Sciences Signs Contract With Leading Wound Care Company for Exclusive Distribution of BIOGUARD(TM) Barrier Dressings
Devices Wound Care Distribution
 HSMN NewsFeed - 9 Feb 2010
TomoTherapy Enters Australian Market With Purchase by Royal Brisbane & Women's Hospital
Devices Oncology Distribution
 HSMN NewsFeed - 15 Jan 2010
St. Jude Medical Announces Sponsorship of SCD-HeFT 10-Year Follow-Up Study
Devices Cardiology
 HSMN NewsFeed - 5 Jan 2010
Derma Sciences Signs Three-Year Contract With Leading Global Healthcare Company
Devices Wound Care
 HSMN NewsFeed - 30 Dec 2009
FDA Accepts NDA Filing for Retigabine
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Dec 2009
Derma Sciences Obtains Exclusive Worldwide Rights to MEDIHONEY(R)
Devices Wound Care Licensing
 HSMN NewsFeed - 18 Dec 2009
Mannatech Granted Injunction on Patents Related to Ambrotose(R) Product Infringed by Green Life and Xiong Lo
Biopharmaceuticals Litigation
 HSMN NewsFeed - 14 Dec 2009
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Dec 2009
Watson Completes Acquisition of Arrow Group
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Nov 2009
Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing
Devices Cardiology Personnel
 HSMN NewsFeed - 9 Nov 2009
VIVA 2009 Late-Breaking Trials Highlight Advances in Interventional Treatments of Peripheral Arterial Disease
Devices Interventional
 HSMN NewsFeed - 5 Nov 2009
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Oct 2009
Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
Biopharmaceuticals
 HSMN NewsFeed - 28 Oct 2009
FDA Issues Guidance for Derma Sciences' Exclusive Wound Dressing With pDADMAC
Devices Wound Care FDA
 HSMN NewsFeed - 8 Oct 2009
Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
Biopharmaceuticals Generics
 HSMN NewsFeed - 24 Sep 2009
ULURU Inc. Presents Data on Negative Pressure Related to Altrazeal(TM) at the Diabetic Limb Salvage Conference in Washington, D.C.
Devices Wound Care
 HSMN NewsFeed - 24 Sep 2009
Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Sep 2009
U.K. NICE Updates Clinical Guidelines to Support Use of Essure(R)
Devices
 HSMN NewsFeed - 22 Sep 2009
Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in Second-Line Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Sep 2009
Wright Medical Group, Inc. Establishes Direct Australian Subsidiary
Devices Orthopaedic
 HSMN NewsFeed - 16 Sep 2009
ULURU Inc. Presents Results of First Randomized Clinical Trial for Altrazeal(TM) at the Symposium on Advanced Wound Care (SAWC) Fall Meeting in Washington D.C.
Devices Wound Care
 HSMN NewsFeed - 14 Sep 2009
Lilly Names New Business Leaders
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2009
AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Jul 2009
Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
Biopharmaceuticals
 HSMN NewsFeed - 8 Jul 2009
Coherex Medical's Coherex FlatStent EF PFO Closure System Granted CE Mark Clearance for Closing PFOs - a Common Heart Defect; Company to Begin Sales/Marketing Efforts in Europe
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 15 Jun 2009
Cameron Health Announces CE Mark of the Minimally Invasive Totally Subcutaneous Implantable Defibrillator for Treatment of Sudden Cardiac Arrest
Devices Cardiology Regulatory
 HSMN NewsFeed - 20 May 2009
Pfizer Expands Its Generics Portfolio Through Innovative Licensing Deals, Increasing Access To Medicines For Billions Worldwide
Biopharmaceuticals Generics Licensing
 HSMN NewsFeed - 19 May 2009
NEVO Sirolimus-Eluting Coronary Stent Yields Superior Results to Taxus Liberte Stent in Pivotal Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2009
Biovail Announces Acquisition of Worldwide Rights to Tetrabenazine
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 14 May 2009
RF Surgical and Medline Announce a New Expanded Non-Exclusive Distribution Agreement for the RF Surgical Detection System
Devices Distribution
 HSMN NewsFeed - 7 May 2009
Paladin Labs and Isotechnika Inc. Form Partnership for Commercialization of Voclosporin
Biopharmaceuticals
 HSMN NewsFeed - 5 May 2009
ULURU Inc. Announces Altrazeal(TM) Clinical Experience Published in the International Wound Journal
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 3 May 2009
Integra LifeSciences Features CUSA NXT System At American Association of Neurological Surgeons Annual Meeting
Devices Neurosurgery
 HSMN NewsFeed - 22 Apr 2009
MediciNova Reports Final Data from Phase II MN-221 Emergency Department Clinical Trial (MN-221-CL-006); Hospitalization Rates Decrease 45 Percent With MN-221 Plus Standardized Care in Asthma Patients
Biopharmaceuticals
 HSMN NewsFeed - 21 Apr 2009
First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure
Devices Cardiology
 HSMN NewsFeed - 7 Apr 2009
Pfizer Announces Operating Structure and Select Senior Leadership Posts to Be Effective Immediately Upon Close of Wyeth Acquisition
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 6 Apr 2009
ULURU Inc. Signs Offer Letter to Acquire York Pharma plc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Mar 2009
Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Mar 2009
I-Flow Announces Letter of Intent with B. Braun for Exclusive International Distribution of ON-Q Products
Devices Distribution
 HSMN NewsFeed - 19 Mar 2009
Inverness Medical Innovations Agrees to Acquire 'Second Territory' Rapid Diagnostics Business of ACON
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 12 Mar 2009
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Mar 2009
BIOLASE and Henry Schein Expand Exclusive Licensing and Distribution Agreement
Devices Distribution Dental
 HSMN NewsFeed - 13 Feb 2009
MEDIHONEY(TM) Dressings Shown to Help Improve Outcomes of Non-Healing Venous Leg Ulcers in Recent Case Series
Devices Wound Care
 HSMN NewsFeed - 30 Jan 2009
REVLIMID Receives Preliminary Positive Recommendation from National Institute for Health and Clinical Excellence (NICE) for Use in the National Health Service (NHS) in England and Wales
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Dec 2008
Cambridge Laboratories Announces Approval of Tetrabenazine in Spain
Biopharmaceuticals Reimbursement Distribution
 HSMN NewsFeed - 1 Dec 2008
Cambridge Laboratories Announces Launch of XENAZINE(R) (Tetrabenazine) in the US
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Nov 2008
Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Oct 2008
Derma Sciences Announces Commercial Launch of XTRASORB(TM)
Devices Wound Care
 HSMN NewsFeed - 16 Oct 2008
Abraxis BioScience and Specialised Therapeutics Australia Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in Australia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Oct 2008
Elixir Medical Corporation Announced Positive First-In-Man Results from Three Drug Eluting Coronary Stent Systems
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Oct 2008
New Data Shows Abbott's Bioabsorbable Drug Eluting Stent is Absorbed Within Two Years - Leaving Behind Functioning Blood Vessels
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Oct 2008
Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Oct 2008
Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Oct 2008
Natus Medical to Acquire Products from BrainZ Instruments Limited
Devices Monitoring Acquisitions
 HSMN NewsFeed - 26 Sep 2008
CHMP Recommends Approval of Olanzapine Long-acting Injection for Maintenance Treatment of Schizophrenia in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Sep 2008
Cambridge Laboratories Announces New Marketing Arrangements for XENAZINE(R) in North America
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Sep 2008
Medtronic Starts U.S. and International Trials of Endeavor(R) Resolute Drug-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Sep 2008
Biovitrum to Acquire Kepivance(R) and Stemgen(R) and Exclusively License Kineret(R) from Amgen
Biopharmaceuticals Acquisitions Licensing
 HSMN NewsFeed - 10 Sep 2008
Cook Medical Completes Enrollment in First International Trial of First-of-Its-Kind Drug-Eluting Peripheral Stent
Devices Interventional
 HSMN NewsFeed - 8 Sep 2008
CoreValve Announces Successful Completion of Initial Series of Proctored Cases in Australia and New Zealand Using Its ReValving(R) System for Percutaneous Aortic Valve Replacement
Devices Cardiology
 HSMN NewsFeed - 3 Sep 2008
Derma Sciences Announces Launch Plan for MOBILITY1(TM) Intermittent Compression Therapy Device
Devices
 HSMN NewsFeed - 28 Aug 2008
CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving(R) System for Percutaneous Aortic Valve Replacement
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Aug 2008
Derma Sciences Announces Latest Exclusive Technology Distribution Agreement
Devices Wound Care Distribution
 HSMN NewsFeed - 26 Aug 2008
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 18 Aug 2008
Cambridge Laboratories Announces FDA Approval of XENAZINE(R) (tetrabenazine) in the US
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 Aug 2008
U.S. Food and Drug Administration Approves Viread(R) for Chronic Hepatitis B in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Aug 2008
GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 1 Aug 2008
Gilead Sciences and Merck & Co., Inc. Enter Into an Agreement to Register and Distribute HIV Medication Atripla(R) (Efavirenz 600 mg/ Emtricitabine 200 mg/ Tenofovir Disoproxil Fumarate 300 mg) in Twelve Countries
Biopharmaceuticals HIV/AIDS Distribution
 HSMN NewsFeed - 9 Jul 2008
Derma Sciences Achieves Significant Commercialization Milestone With Reimbursement Codes for MEDIHONEY(TM)
Devices Wound Care Reimbursement
 HSMN NewsFeed - 30 Jun 2008
Odanacatib, an Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Jun 2008
Derma Sciences Launches Two New MEDIHONEY(TM) Formulations
Devices Wound Care
 HSMN NewsFeed - 25 Jun 2008
U.S. Multicenter Trial Shows Positive Results Using Cook Medical's Zenith Abdominal Aortic Aneurysm Endovascular Stent Compared to Open Surgical Repair
Devices Interventional
 HSMN NewsFeed - 18 Jun 2008
Derma Sciences MEDIHONEY(TM) Helps to Save Patient's Limb
Devices Wound Care
 HSMN NewsFeed - 17 Jun 2008
Randomized Controlled Clinical Trial Shows Derma Sciences MEDIHONEY(TM) Eradicates MRSA From Chronic Venous Ulcers
Devices Wound Care
 HSMN NewsFeed - 1 Jun 2008
New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 May 2008
Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 May 2008
Derma Sciences Announces $6 Million Agreement
Devices Wound Care
 HSMN NewsFeed - 21 May 2008
Sirtex Launches Global Clinical Trial Comparing the Use of SIR-Spheres(R) Microspheres Plus Chemotherapy versus Chemotherapy Alone as First Line Treatment for Metastatic Colorectal Cancer
Devices Oncology
 HSMN NewsFeed - 15 May 2008
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisation or Death in Patients With Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 15 May 2008
International Endeavor Registry Reports Safety and Performance of Medtronic Drug-Eluting Stent in Diverse Patient Population
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
Cardiovascular Researchers Use MEDIHONEY(TM) on Sternal Infections Following Open-Heart Procedures
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 13 May 2008
ENDEAVOR II Four-Year Results Demonstrate Long-Term Safety and Durable Efficacy of Medtronic Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Apr 2008
Derma Sciences Receives Third FDA Clearance for MEDIHONEY(TM) Wound & Burn Dressings
Devices Wound Care FDA
 HSMN NewsFeed - 25 Apr 2008
European Commission Approves Viread(R) for Chronic Hepatitis B
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Apr 2008
Elekta Announces First Linear Accelerator Order in New Zealand
Devices Oncology
 HSMN NewsFeed - 23 Apr 2008
Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn Dressings
Devices Wound Care Group Purchasing
 HSMN NewsFeed - 15 Apr 2008
Biogen Idec and Elan Present New TYSABRI(R) Data at the 60th Annual Meeting of the American Academy of Neurology
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Apr 2008
Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 8 Apr 2008
New Study Shows the Use of MEDIHONEY(TM) Wound & Burn Dressing is Associated With Reduction in Wound Size
Devices Wound Care
 HSMN NewsFeed - 4 Apr 2008
Angiotech announces commercial launch of Cook Medical's Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
Devices Interventional
 HSMN NewsFeed - 3 Apr 2008
Derma Sciences Closes $6.1 Million Private Placement
Biopharmaceuticals Wound Care Venture Capital
 HSMN NewsFeed - 1 Apr 2008
Exactech Names Industry Veteran Daniel Berdat as VP of International Sales and Marketing
Devices Personnel
 HSMN NewsFeed - 1 Apr 2008
3M Acquires Les Entreprises Solumed Inc.
Devices Acquisitions
 HSMN NewsFeed - 1 Apr 2008
Elixir Medical Announces Positive Nine-Month Results From the Excella Novolimus-Eluting Coronary Stent System First-In-Man Study
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Mar 2008
SPIRIT II Explores Long-Term Performance of XIENCE V Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Mar 2008
Filter Fails to Improve PCI Outcomes in Acute Coronary Syndromes
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Mar 2008
Sirtex Announces New President for U.S. Operations
Devices Personnel
 HSMN NewsFeed - 19 Mar 2008
Cardium's InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
Devices Distribution
 HSMN NewsFeed - 19 Mar 2008
Supplemental Application for GARDASIL(R), Merck's Cervical Cancer Vaccine, Designated Priority Review by the U.S. FDA for Use in Women 27 through 45
Biopharmaceuticals
 HSMN NewsFeed - 12 Mar 2008
AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Feb 2008
Medtronic Announces First Human Use of Its Bifurcation Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Feb 2008
ULURU Inc. Provides Details On Altrazeal(TM) Launch
Devices Wound Care
 HSMN NewsFeed - 11 Feb 2008
Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
Diagnostics
 HSMN NewsFeed - 11 Feb 2008
Cook Medical Enrolls First U.S. Patient in STABLE Aortic Dissection Trial
Devices Interventional
 HSMN NewsFeed - 11 Feb 2008
Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
Diagnostics
 HSMN NewsFeed - 31 Jan 2008
FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Jan 2008
Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Jan 2008
Cook Medical Begins Patient Enrollment in STABLE Aortic Dissection Trial
Devices
 HSMN NewsFeed - 18 Jan 2008
Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 14 Jan 2008
FDA Approves TYSABRI(R) for the Treatment of Moderate-to-Severe Crohn's Disease
Biopharmaceuticals FDA Gastroenterology
 HSMN NewsFeed - 7 Jan 2008
Biogen Idec and Elan Provide Update on Utilization, Safety and Total Patient Exposure of TYSABRI(R) in Patients with Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Dec 2007
TomoTherapy Signs Distribution Agreements in Six New Markets
Devices Oncology Distribution
 HSMN NewsFeed - 6 Dec 2007
Ipsen Grants Galderma Exclusive Rights to Promote and Distribute Dysport(R) in Aesthetic Medicine and Dermatological Indications in Brazil, Argentina and Paraguay
Biopharmaceuticals Distribution Dermatology
 HSMN NewsFeed - 3 Dec 2007
Early Treatment with COPAXONE(R) Demonstrated Robust Protection against Progression to Clinically Definite Multiple Sclerosis in the PreCISe Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Nov 2007
Health Canada Approves Conceptus' Third Generation Essure(R) Permanent Birth Control System
Devices Regulatory
 HSMN NewsFeed - 15 Nov 2007
Cook Medical's Zenith Endograft Captures Leading Market Share Position in Endovascular Aortic Repair Global Market
Devices Interventional
 HSMN NewsFeed - 14 Nov 2007
Derma Sciences Receives Reimbursement Codes for their Novel MOBILITY1(TM) Intermittent Pneumatic Compression Therapy System
Devices Reimbursement
 HSMN NewsFeed - 12 Nov 2007
Derma Sciences Receives Reimbursement Codes for their New MEDIHONEY(TM) Wound & Burn Dressings
Devices Wound Care Reimbursement
 HSMN NewsFeed - 12 Nov 2007
Actelion: Pivlaz (Clazosentan) Phase III Study Initiated to Demonstrate Prevention of Vasospasm-Related Morbidity and All-Cause Mortality After Aneurysmal Subarachnoid Hemorrhage
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 4 Nov 2007
New Data Presented on GARDASIL(R), Merck's Cervical Cancer Vaccine, in Women Through Age 45
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Oct 2007
Sequoia Pharmaceuticals Announces Appointment of Steven D. Skolsky as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2007
Orexo Signs Distribution Agreement with Hospira in Asia for Pain Product Rapinyl(TM)
Biopharmaceuticals Distribution
 HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 Oct 2007
Abbott Announces Positive One-Year Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Oct 2007
Derma Sciences Announces Launch Of MEDIHONEY(TM) Wound Care Dressings
Devices Wound Care
 HSMN NewsFeed - 16 Oct 2007
Ingen Announces New Medical Technology, OxyAlert(TM)
Devices FDA
 HSMN NewsFeed - 15 Oct 2007
Elan and Biogen Idec Announce That FDA Will Extend Regulatory Review Period for TYSABRI(R) for Crohn's Disease
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 11 Oct 2007
Biogen Idec and Elan Provide Update on Utilization and Safety of TYSABRI(R) in Patients with Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Oct 2007
Mylan Announces Appointment of John Montgomery as President, Asia Pacific
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Sep 2007
Cook Medical Receives FDA Approval to Begin U.S. Phase I Clinical Trial for Cook Zenith(R) Dissection Endovascular System
Devices Interventional FDA
 HSMN NewsFeed - 20 Sep 2007
Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Biopharmacetuicals Oncology
 HSMN NewsFeed - 20 Sep 2007
Keraplast Technologies Announces Breakthrough Approval of Functional Keratin Wound Dressings
Devices Wound Care Regulatory
 HSMN NewsFeed - 18 Sep 2007
Increased Bone Mineral Density Seen in Phase IIB Study with Odanacatib, Formerly MK-0822, An Investigational Cathepsin K Inhibitor
Biopharmaceuticals
 HSMN NewsFeed - 17 Sep 2007
Mpex Pharmaceuticals Names Dr. Jeffery Loutit as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Sep 2007
Angiox(R) (Bivalirudin) Alone Reduced Early Bleeding and Resulted in Similar One-Year Mortality Compared to Heparins Plus GP IIb/IIIa Combination Therapy in ACS Patients Undergoing Angioplasty
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 28 Aug 2007
Phase III Trial Finds Pharmaxis' Bronchitol Effective
Biopharmaceuticals
 HSMN NewsFeed - 24 Aug 2007
Hana Biosciences Appoints Dr. Steven R. Deitcher President and CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Aug 2007
Pacific Beach BioSciences and Dong Wha Pharmaceuticals Sign Exclusive License Agreement to Develop and Commercialize Zabofloxacin (PB-101, DW-224a)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 9 Aug 2007
Review Examines the Use of Sirtex's SIR-Spheres(R) Microspheres in Patients with Hepatic Colorectal Cancer Metastases
Devices Oncology
 HSMN NewsFeed - 7 Aug 2007
Cook Medical Submits Final PMA Modules to FDA for Approval of the Cook Zenith TX2(R) Thoracic Aortic Aneurysm Endovascular Graft
Devices Interventional
 HSMN NewsFeed - 25 Jul 2007
Positive Opinion for Expanded Label of CUBICIN Received from European Regulatory Authority; Decision Expected This September
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Jul 2007
Angiotech's corporate partner, Boston Scientific, announces first human use of TAXUS(R) Petal(TM) Bifurcation Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Jul 2007
Boston Scientific Announces First Human Use of TAXUS(R) Petal(TM) Bifurcation Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Jul 2007
Sirtex Announces New Medical Director for U.S. Operations
Devices Oncology Personnel
 HSMN NewsFeed - 10 Jul 2007
International Clinical Trial Shows Positive Results Using Cook Medical's Zenith TX2(R) Thoracic Aortic Aneurysm Endovascular Graft Compared to Open Surgical Repair
Devices Interventional
 HSMN NewsFeed - 20 Jun 2007
Merck Provides Update on Status of Supplemental Biologics License Applications (sBLA) for GARDASIL(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Jun 2007
Derma Sciences Receives Health Canada Clearance for API-MED(TM) Antimicrobial Dressings with Active Manuka Honey
Devices Wound Care Regulatory
 HSMN NewsFeed - 4 Jun 2007
Pharmion Announces French ATU Granted for Use of Thalidomide for Elderly Patients With Untreated Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 4 Jun 2007
Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2007
Derma Sciences Announces Preliminary Results of Study Involving Active Manuka Honey at European Wound Management Conference
Wound Care
 HSMN NewsFeed - 31 May 2007
HalcyGen to target US$1b drugs market with licenses
Biopharmaceuticals Generics Licensing
 HSMN NewsFeed - 22 May 2007
Abbott Announces Positive Nine-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2007
Portland Orthopaedics resumes control of US hip distribution
Devices Orthopaedic Distribution
 HSMN NewsFeed - 17 May 2007
Data Published in The Lancet Show GARDASIL(R) was 100 Percent Effective in Preventing High-Grade Vulvar and Vaginal Lesions Caused by HPV Types 16 and 18
Biopharmaceuticals
 HSMN NewsFeed - 9 May 2007
New England Journal of Medicine Publishes New Data on GARDASIL(R), Merck's Cervical Cancer Vaccine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 May 2007
New Research Results Show That Investigational Drug Phenoxodiol Targets Cancer Protein, Causing Cancer Cell Death
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Apr 2007
Merck Submits New Cross-Protection Data for GARDASIL(R) to the FDA and Seeks New Indications for Vaginal and Vulvar Cancers
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Apr 2007
Protemix Raises US$14.5 Million in First Close of Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Mar 2007
Ric Tiplady Joins WaveLight as VP of Business Development
Devices Ophthalmology Personnel
 HSMN NewsFeed - 24 Mar 2007
Abbott Announces Positive Six-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Mar 2007
CDC Finalizes Advisory Panel Recommendations for GARDASIL(R), Merck's Cervical Cancer Vaccine
Biopharmaceuticals
 HSMN NewsFeed - 1 Mar 2007
EMEA Accepts for Review Thalidomide Pharmion(R) Marketing Authorization Application for Untreated Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 28 Feb 2007
Medtronic Announces Succession Plans for CEO and COO
Devices Personnel
 HSMN NewsFeed - 26 Feb 2007
GSK Initiates First Global Phase III Study of TYKERB(R) (lapatinib) in Head and Neck Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Feb 2007
Wyeth Pharmaceuticals Announces Organizational Change
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Feb 2007
Sirtex Supports the First Pilot Study Evaluating SIR-Spheres(R) Microspheres in Combination with Bevacizumab and Chemotherapy as a First Line Treatment for Metastatic Colorectal Cancer
Devices Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Feb 2007
Nexavar Shown to Significantly Extend Survival for Patients with Advanced Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Feb 2007
Proacta Inc Completes $35M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Feb 2007
Phase III Bronchitol Clinical Trial Fully Recruited
Biopharmaceuticals
 HSMN NewsFeed - 31 Jan 2007
Schering-Plough Appoints Shaju Backer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jan 2007
Independent Study Concludes Masimo Engineering Prototype Is the First Technology to Measure Total Hemoglobin Continuously and Noninvasively, Wins STA Technology Award
Devices Monitoring
 HSMN NewsFeed - 23 Jan 2007
Pharmion Submits European Marketing Authorization Application for Thalidomide Pharmion(R) for Untreated Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Jan 2007
bioMerieux Licenses Technology From Norchip to Launch a HPV Test For Cervical Cancer Risk Detection
Diagnostics Oncology Licensing
 HSMN NewsFeed - 15 Jan 2007
Portland Orthopaedics’ Equator Plus Cup Launched in US
Devices Orthopaedic
 HSMN NewsFeed - 4 Jan 2007
Schering-Plough and OraSure Technologies Sign Agreement for Development and Promotion of Rapid Point-of-Care Oral Hepatitis C Test
Diagnostics
 HSMN NewsFeed - 28 Dec 2006
Landmark Tykerb(R) (Lapatinib) Data Published in the New England Journal of Medicine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Dec 2006
3M Completes Sale of its Pharmaceuticals Business in Asia Pacific Region
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Nov 2006
Marshall Edwards, Inc. Appoints Professor Bryan Williams as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Nov 2006
Wyeth Announces Executive Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2006
Merck Launches National Advertising Campaign for GARDASIL(R), Merck's New Cervical Cancer Vaccine
Biopharmaceuticals
 HSMN NewsFeed - 9 Nov 2006
3M Reaches Agreements to Sell its Pharmaceuticals Business
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Nov 2006
Merck's Cervical Cancer Vaccine, GARDASIL(R), Added to the CDC Vaccines for Children Contract
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Oct 2006
TAXUS(R) stents demonstrate excellent efficacy and safety in studies presented at TCT 2006
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 25 Oct 2006
Medtronic Announces Positive Results for Endeavor RESOLUTE Drug-Eluting Coronary Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Oct 2006
Safety and Efficacy Benefits of Next-Generation TAXUS(R) Liberte(TM) Stent Sustained at Twelve Months
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2006
Abbott Reports Initial Results From World's First Clinical Trial Featuring a Fully Bioabsorbable Drug-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2006
OccuLogix and Asahi Kasei Medical Sign Rheofilter'TM' SR Agreement
Devices Ophthalmology Distribution
 HSMN NewsFeed - 17 Oct 2006
Abbott to Present New Data Across Its Vascular Portfolio at TCT 2006
Devices Interventional Cardiology
Return to NewsFeed  

 Additional items found! 203

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 203 additional stories matching:
ZEAL
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!